The American Conference Institute’s FDA Boot Camp has prepared life science attorneys and executives to master the fundamentals of FDA regulation for more than 15 years. At the 36th iteration of this conference, WilmerHale Partner Emily Whelan will lead an in-depth workshop, “Hatch-Waxman and BPCIA in the Trenches: Exclusivity and Bioequivalency Working Group.”
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
